A piece circulating in the direct primary care community made a confident claim: that the best DPC physicians will not need employer-aligned models or adjacent entities because individual consumer demand will sustain them. Fully booked by individuals, insulated from institutional complexity, answerable to no one but their patients.

It is a satisfying idea. It is also an empirically untested one.

The history of DPC is built on physicians willing to challenge entrenched assumptions about how primary care is financed and delivered. That same spirit of disciplined skepticism should now be turned inward, toward the assumptions the movement is making about its own future.

Where the concern is valid

The caution about insurance-adjacent entities entering the DPC ecosystem is not unreasonable. Many physicians who built early DPC practices did so specifically to escape administrative bloat, misaligned incentives, and the moral injury of traditional managed care. That history matters and deserves respect.

Some entities positioning themselves near DPC do oversimplify the path to scale. Physicians are right to be wary of arrangements that promise growth while quietly reintroducing complexity, data extraction, or misaligned financial incentives. A third-party administrator or navigation vendor that insists on visit-level reporting and productivity-style metrics can quickly make DPC feel like RVUs by another name. History gives the DPC movement good reason for skepticism.

Stopping the analysis there is economically incomplete.

The demand reality the purity argument skips

The central assumption in purity-based arguments is that clinical excellence generates sufficient individual consumer demand to sustain any DPC practice, in any market, at any scale. The household income data suggests this confidence deserves scrutiny.

According to the Bureau of Labor Statistics 2024 Consumer Expenditure Survey, average annual household expenditures were $78,535 against average pre-tax income of $104,207. Health care consumed 7.9 percent of total household spending, but that figure includes insurance premiums, prescription costs, and other obligatory expenses that leave minimal elasticity for adding a new monthly subscription on top.

The income quintile picture sharpens the point. The lower income bound for the middle quintile in 2024 was $57,452. At a typical DPC membership of $100 to $150 per month per adult, a household in that income band is being asked to redirect $1,200 to $1,800 annually from an already compressed budget, after paying for the catastrophic insurance coverage that DPC still requires.

In affluent markets, individual consumer demand can absolutely sustain a well-positioned DPC practice. The behavioral economics are different in those zip codes, health care is not discretionary when income provides margin. For the median American household, however, a DPC membership is not competing with specialty coffee; it is competing with rent increases, food costs, and the compounding pressures of the past four years of inflation.

The assertion that the best physicians will always be fully booked by individuals may be directionally true in some markets. It fails as a universal model for DPC growth.

The employer channel is not a moral compromise

The KFF 2025 Employer Health Benefits Survey found that employer-sponsored insurance currently covers 154 million Americans under age 65, roughly 55 percent of the total workforce. Family premiums reached $26,993 annually, a 26 percent increase over five years. Employers are under sustained cost pressure, and they are looking for structural alternatives, not incremental adjustments.

Whether we prefer that structure or not, employer-sponsored coverage remains the primary health care gateway for the majority of working Americans. DPC that remains almost entirely dependent on individual discretionary spend will naturally concentrate in higher-income, higher-awareness populations. That may preserve ideological coherence, but it also narrows reach, and leaves the employer channel to be designed by others.

If DPC clinicians ignore the employer channel, those arrangements will be built anyway, by brokers, TPAs, health systems, and venture-backed platforms whose primary obligations are not clinical integrity. Being at the table does not mean capitulating; it means negotiating the guardrails.

The question the purity argument sidesteps is not whether employer-aligned DPC is philosophically pure. The question is whether physicians help design those structures now, or react to them later after they have been built without clinical input. History suggests the latter is rarely the better outcome.

Scale is not a moral category. Poor structure is.

There is a meaningful difference between “this model reintroduces managed care” and “some models reintroduce managed care.” The first statement is ideology. The second is an analytical claim that requires evidence about specific contract structures, governance arrangements, and operational controls.

Private equity participation is not inherently misaligned with good care delivery. Capital has funded important health care infrastructure for decades. But capital does carry expectations around growth velocity and margin discipline, and without careful governance, those pressures can gradually reshape operational priorities. A PE-backed DPC platform with transparent panels and hard stop ratios is fundamentally different from one that quietly doubles panel size to hit growth targets.

The same is true of health system entry into the employer space, when done thoughtfully, it can improve coordination; when done poorly, it recreates the referral capture dynamics independent physicians worked to escape.

These risks are real, but they are not inevitable. Structure still matters. Panel discipline still matters. Contract design still matters. Clinical governance still matters. Lumping every non-retail model into the category of corruption prevents the kind of structural differentiation the movement actually needs to protect itself.

The more productive questions

Instead of treating the next phase of DPC as a binary choice between independence and corruption, the field benefits from asking more precise questions:

1. Which partnership structures preserve physician autonomy and panel discipline?
2. Which contracting models maintain price transparency rather than reintroducing utilization management through the back door?
3. Which employer arrangements expand access without recreating the administrative burden physicians left behind?
4. Where does new infrastructure add clinical value versus simply adding margin layers?

These are harder questions than drawing bright ideological lines. They are also the questions DPC physicians should bring to every conversation with brokers, employers, platforms, and capital partners, and they will determine whether DPC remains a niche success story in affluent markets or becomes a durable component of how primary care is delivered across income bands.

Closing

The DPC movement gained momentum by challenging entrenched assumptions about how primary care must be financed and delivered. That same disciplined skepticism should now apply to the movement’s own assumptions about demand, distribution, and scale.

Purity may protect identity for a season. The household income data, the employer cost pressure data, and the market penetration data all point in the same direction: adaptation determines longevity.

The next chapter of DPC will not be shaped by who enters the market. It will be shaped by who designs the structures that govern it, and whether physicians are at that table when the designs are made.

Dana Y. Lujan is a health care strategist and operator with more than twenty years of experience across payers, providers, and health systems. She is the founder of Wellthlinks, a consulting firm that helps employers and providers redesign care models through concierge and direct primary care, and author of The CEO Physician: Strategic Blueprint for Independent Medicine. Dana has led multi-state network development, payer contracting, financial modeling, and compliance initiatives that strengthen provider sustainability and employer value. She previously served as president of the Nevada chapter of HFMA and is pursuing a JD to expand her expertise in health care law and compliance. She has been featured in Authority Magazine and publishes on KevinMD, MedCity News, and  Medium, where she writes on health care innovation, direct primary care, concierge medicine, employer contracting, and compliance. She has forthcoming BenefitsPRO. Additional professional updates can be found on LinkedIn and Instagram.